SOX18

Chr 20ARAD

SRY-box transcription factor 18

Also known as: HLTRS, HLTS

This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. This protein plays a role in hair, blood vessel, and lymphatic vessel development. Mutations in this gene have been associated with recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
MultiplemechanismAR/ADLOEUF 1.052 OMIM phenotypes
Clinical SummarySOX18
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.34) despite low pLI — interpret in context.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 156 VUS of 224 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.05LOEUF
pLI 0.151
Z-score 1.50
OE 0.34 (0.141.05)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.86Z-score
OE missense 0.79 (0.670.93)
104 obs / 131.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.34 (0.141.05)
00.351.4
Missense OE?0.79 (0.670.93)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 2 / 6.0Missense obs/exp: 104 / 131.8Syn Z: -0.00
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSOX18-related hypotrichosis-lymphoedema-telangiectasia syndromeOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6065th %ile
GOF
0.5858th %ile
LOF
0.51top 25%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

DNFunctional analysis confirmed that SOX18wt has potent trans-activation properties, while SOX18DN displays dominant-negative effect.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 24460943

ClinVar Variant Classifications

224 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic5
VUS156
Likely Benign47
Benign7
Conflicting6
3
Pathogenic
5
Likely Pathogenic
156
VUS
47
Likely Benign
7
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
2
0
0
3
Likely Pathogenic
5
0
0
0
5
VUS
3
149
4
0
156
Likely Benign
0
6
3
38
47
Benign
0
1
4
2
7
Conflicting
6
Total91581140224

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

38 pathogenic / likely-pathogenic (of 51) ClinVar copy-number / structural variants overlap SOX18 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SOX18 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →